Cancer Immunotherapy Month | I'M the Answer to Cancer™ | Sean's Patient Story

Sean, a healthy 20-year-old, suffered a seizure on 9/24/2020, leading to the discovery of a brain tumor later diagnosed as high-grade glioma. Despite the grim diagnosis, Sean's life was transformed by immunotherapy, which played a crucial role in his successful treatment.
--
Established in 1953, the Cancer Research Institute (CRI) is a 501(c)(3) nonprofit organization dedicated to harnessing our immune system’s power to control and potentially cure all cancers. Our mission: Save more lives by fueling the discovery and development of powerful immunotherapies for all types of cancer. To accomplish this, we rely on donor support and collaborative partnerships to fund and carry out the most innovative clinical and laboratory research around the world, support the next generation of the field’s leaders, and serve as the trusted source of information on immunotherapy for cancer patients and their caregivers. www.cancerresearch.org
Cancer Research Institute is a registered 501(c)(3) nonprofit under EIN 13-1837442. Donations are tax-deductible to the fullest extent allowable under the law.

[@DS-lv9ic]

Sean, you've come a long way since that day in 2020 at the StoneWater Golf Club. I'm so proud of the man you've become. I'm so impressed that you're sharing your experience and offering hope to other glioma patients. LuvG

[@drnewgunner4359]

When you say high-grade glioma, do you mean GBM or Something ?

[@CancerResearchInstitute]

Hi, there are several types of brain cancer, classified by the type of cell from which they originate, including astrocytomas, gliomas, and meningiomas. Glioma originates in glial cells that support and protect neurons. Glioblastoma (GBM), which forms from astrocytes, is the most dangerous and aggressive form of brain cancer. For more info, take a look at our website: www.cancerresearch.org/cancer-types/brain-cancer